Factors Related to Increasing Prevalence of Resistance to Ciprofloxacin and Other Antimicrobial Drugs inNeisseria gonorrhoeae, United States
Authors:
- Edward GoldsteinEGEdward Goldstein
- Robert D. KirkcaldyRKRobert D. Kirkcaldy
- David ReshefDRDavid Reshef
- Stuart BermanSBStuart Berman
- Hillard WeinstockHWHillard Weinstock
- Pardis SabetiPSPardis Sabeti
- Carlos Del RioCRCarlos Del Rio
- Geraldine HallGHGeraldine Hall
- Edward W. HookEHEdward W. Hook
- Marc LipsitchMLMarc Lipsitch
Open Access
- 1 August 2012
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 18 (8) , 1290-1297
Abstract
Using data from the Gonococcal Isolate Surveillance Project, we studied changes in ciprofloxacin resistance in Neisseria gonorrhoeae isolates in the United States during 2002–2007. Compared with prevalence in heterosexual men, prevalence of ciprofloxacin-resistant N. gonorrhoeae infections showed a more pronounced increase in men who have sex with men (MSM), particularly through an increase in prevalence of strains also resistant to tetracycline and penicillin. Moreover, that multidrug resistance profile among MSM was negatively associated with recent travel. Across the surveillance project sites, first appearance of ciprofloxacin resistance in heterosexual men was positively correlated with such resistance for MSM. The increase in prevalence of ciprofloxacin resistance may have been facilitated by use of fluoroquinolones for treating gonorrhea and other conditions. The prominence of multidrug resistance suggests that using other classes of antimicrobial drugs for purposes other than treating gonorrhea helped increase the prevalence of ciprofloxacin-resistant strains that are also resistant to those drugs.Keywords
This publication has 23 references indexed in Scilit:
- The use of cephalosporins for gonorrhea: the impending problem of resistanceExpert Opinion on Pharmacotherapy, 2009
- Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporinsCurrent Opinion in Infectious Diseases, 2009
- Analysis of trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Australia, 1997 2006Journal of Antimicrobial Chemotherapy, 2007
- Distinguishing importation from diversification of quinolone-resistant Neisseria gonorrhoeae by molecular evolutionary analysisBMC Ecology and Evolution, 2007
- Neisseria gonorrhoeae Isolates with Reduced Susceptibility to Cefixime and Ceftriaxone: Association with Genetic Polymorphisms in penA , mtrR , porB1b , and ponAAntimicrobial Agents and Chemotherapy, 2007
- Update on the Management of Gonorrhea in Adults in the United StatesClinical Infectious Diseases, 2007
- Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotypeInternational Journal of Antimicrobial Agents, 2006
- Changing Epidemiologic Profile of Quinolone‐ResistantNeisseria gonorrhoeaein LondonThe Journal of Infectious Diseases, 2005
- Prevalence of Rectal, Urethral, and Pharyngeal Chlamydia and Gonorrhea Detected in 2 Clinical Settings among Men Who Have Sex with Men: San Francisco, California, 2003Clinical Infectious Diseases, 2005
- Gonorrhea in the United States, 1981-1996Sexually Transmitted Diseases, 1998